Alexander Rakitko
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Alexander Rakitko has a total of 330 co-authors. Here are the top co-authors by number of shared publications:
- Valery Vladimirovich Ilinsky
Bekhterev National Medical Research Center for Psychiatry and Neurology
14 shared publications - Alexander Olegovitch Kibitov
FSBI “V.M. Bekhterev National Research Medical Center for Psychiatry and Neurology” of the Ministry of Health of the Russian Federation; FSBEI HE “Academician I.P. Pavlov First St. Petersburg State Medical University” of the Ministry of Healthcare of Russian Federation
7 shared publications - Ekaterina Vergasova
Genotek Ltd
6 shared publications - Elena V. Kovalenko
Genotek Ltd
6 shared publications - Evgeny Dmitrievich Kasyanov
V.M. Bekhterev National Medical Research Centre for Psychiatry and Neurology
6 shared publications - Galina Elevna Mazo
Department of Social neuropsychiatry V. M. Bekhterev National Medical Research Center for Psychiatry and Neurology Saint-Petersburg Russia
6 shared publications
Latest Publications
- Open Access
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1843103
Machine learning prediction of hypertension integrating polygenic risk scores in inner Eurasian populations
Introduction: Arterial hypertension is one of the leading contributors to cardiovascular morbidity and mortality worldwide. This study aimed to evaluate the performance of polygenic risk scores (PRS) for hypertension in Russia and to develop predictive models integrating PRS and questionnaire-based risk factors for disease risk assessment. Methods: We analyzed a cohort of 175,704 individuals from multiethnic inner Eurasian populations. Published PRS for systolic blood pressure, diastolic blood pressure, and pulse pressure were evaluated for association with hypertension across different ancestry groups. Predictive models integrating PRS and questionnaire-derived risk factors were developed using multiple machine learning tools, including neural networks. Results: PRSs for systolic and diastolic blood pressure showed marked differences between the top and bottom deciles of the PRS distribution, with odds ratios of 6.20 (95% CI: 5.22–7.36) and 6.71 (95% CI: 5.58–8.06), respectively. The PRS for pulse pressure was also strongly associated with hypertension, with an odds ratio of 3.71 (95% CI: 3.16–4.35). All evaluated PRSs were consistently associated with hypertension across several ancestry groups represented in Russia and neighboring regions, including East Slavic populations (Russians, Belarusians, and Ukrainians), populations of the Volga–Ural region, such as Tatars, and West Asian–related groups represented by Armenians and Hemshins. A neural network model integrating PRSs with questionnaire-based risk factors achieved a test ROC-AUC of 0.8245 (95% CI: 0.8114–0.8362), demonstrating robust discriminatory performance for arterial hypertension. Conclusion: Our study demonstrates that previously published PRSs for systolic blood pressure, diastolic blood pressure, and pulse pressure retain substantial predictive value across diverse inner Eurasian populations and provide complementary information beyond conventional questionnaire-based risk factors. Among the evaluated scores, the systolic blood pressure PRS showed the most robust and consistent transferability, remaining informative even in several genetically diverse and underpowered cohorts.
- 8 July 2026
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 13, 1843103
Open AccessMachine learning prediction of hypertension integrating polygenic risk scores in inner Eurasian populations
Introduction: Arterial hypertension is one of the leading contributors to cardiovascular morbidity and mortality worldwide. This study aimed to evaluate the performance of polygenic risk scores (PRS) for hypertension in Russia and to develop predictive models integrating PRS and questionnaire-based risk factors for disease risk assessment. Methods: We analyzed a cohort of 175,704 individuals from multiethnic inner Eurasian populations. Published PRS for systolic blood pressure, diastolic blood pressure, and pulse pressure were evaluated for association with hypertension across different ancestry groups. Predictive models integrating PRS and questionnaire-derived risk factors were developed using multiple machine learning tools, including neural networks. Results: PRSs for systolic and diastolic blood pressure showed marked differences between the top and bottom deciles of the PRS distribution, with odds ratios of 6.20 (95% CI: 5.22–7.36) and 6.71 (95% CI: 5.58–8.06), respectively. The PRS for pulse pressure was also strongly associated with hypertension, with an odds ratio of 3.71 (95% CI: 3.16–4.35). All evaluated PRSs were consistently associated with hypertension across several ancestry groups represented in Russia and neighboring regions, including East Slavic populations (Russians, Belarusians, and Ukrainians), populations of the Volga–Ural region, such as Tatars, and West Asian–related groups represented by Armenians and Hemshins. A neural network model integrating PRSs with questionnaire-based risk factors achieved a test ROC-AUC of 0.8245 (95% CI: 0.8114–0.8362), demonstrating robust discriminatory performance for arterial hypertension. Conclusion: Our study demonstrates that previously published PRSs for systolic blood pressure, diastolic blood pressure, and pulse pressure retain substantial predictive value across diverse inner Eurasian populations and provide complementary information beyond conventional questionnaire-based risk factors. Among the evaluated scores, the systolic blood pressure PRS showed the most robust and consistent transferability, remaining informative even in several genetically diverse and underpowered cohorts.
- Top Cited PapersOpen Access
- 21 May 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (6) , 1402-1417
Genome-wide association study of long COVID
Infections can lead to persistent symptoms and diseases such as shingles after varicella zoster or rheumatic fever after streptococcal infections. Similarly, severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection can result in long coronavirus disease (COVID), typically manifesting as fatigue, pulmonary symptoms and cognitive dysfunction. The biological mechanisms behind long COVID remain unclear. We performed a genome-wide association study for long COVID including up to 6,450 long COVID cases and 1,093,995 population controls from 24 studies across 16 countries. We discovered an association of FOXP4 with long COVID, independent of its previously identified association with severe COVID-19. The signal was replicated in 9,500 long COVID cases and 798,835 population controls. Given the transcription factor FOXP4’s role in lung physiology and pathology, our findings highlight the importance of lung function in the pathophysiology of long COVID.
- 21 May 2025
- Published by Springer Nature in Nature Genetics
- Vol. 57 (6) , 1402-1417
Top Cited PapersOpen AccessGenome-wide association study of long COVID
Infections can lead to persistent symptoms and diseases such as shingles after varicella zoster or rheumatic fever after streptococcal infections. Similarly, severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) infection can result in long coronavirus disease (COVID), typically manifesting as fatigue, pulmonary symptoms and cognitive dysfunction. The biological mechanisms behind long COVID remain unclear. We performed a genome-wide association study for long COVID including up to 6,450 long COVID cases and 1,093,995 population controls from 24 studies across 16 countries. We discovered an association of FOXP4 with long COVID, independent of its previously identified association with severe COVID-19. The signal was replicated in 9,500 long COVID cases and 798,835 population controls. Given the transcription factor FOXP4’s role in lung physiology and pathology, our findings highlight the importance of lung function in the pathophysiology of long COVID.
- Open Access
- 7 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1479717
Deep learning captures the effect of epistasis in multifactorial diseases
Background: Polygenic risk score (PRS) prediction is widely used to assess the risk of diagnosis and progression of many diseases. Routinely, the weights of individual SNPs are estimated by the linear regression model that assumes independent and linear contribution of each SNP to the phenotype. However, for complex multifactorial diseases such as Alzheimer’s disease, diabetes, cardiovascular disease, cancer, and others, association between individual SNPs and disease could be non-linear due to epistatic interactions. The aim of the presented study is to explore the power of non-linear machine learning algorithms and deep learning models to predict the risk of multifactorial diseases with epistasis.Methods: Simulated data with 2- and 3-loci interactions and tested three different models of epistasis: additive, multiplicative and threshold, were generated using the GAMETES. Penetrance tables were generated using PyTOXO package. For machine learning methods we used multilayer perceptron (MLP), convolutional neural network (CNN) and recurrent neural network (RNN), Lasso regression, random forest and gradient boosting models. Performance of machine learning models were assessed using accuracy, AUC-ROC, AUC-PR, recall, precision, and F1 score.Results: First, we tested ensemble tree methods and deep learning neural networks against LASSO linear regression model on simulated data with different types and strength of epistasis. The results showed that with the increase of strength of epistasis effect, non-linear models significantly outperform linear. Then the higher performance of non-linear models over linear was confirmed on real genetic data for multifactorial phenotypes such as obesity, type 1 diabetes, and psoriasis. From non-linear models, gradient boosting appeared to be the best model in obesity and psoriasis while deep learning methods significantly outperform linear approaches in type 1 diabetes.Conclusion: Overall, our study underscores the efficacy of non-linear models and deep learning approaches in more accurately accounting for the effects of epistasis in simulations with specific configurations and in the context of certain diseases.
- 7 January 2025
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1479717
Open AccessDeep learning captures the effect of epistasis in multifactorial diseases
Background: Polygenic risk score (PRS) prediction is widely used to assess the risk of diagnosis and progression of many diseases. Routinely, the weights of individual SNPs are estimated by the linear regression model that assumes independent and linear contribution of each SNP to the phenotype. However, for complex multifactorial diseases such as Alzheimer’s disease, diabetes, cardiovascular disease, cancer, and others, association between individual SNPs and disease could be non-linear due to epistatic interactions. The aim of the presented study is to explore the power of non-linear machine learning algorithms and deep learning models to predict the risk of multifactorial diseases with epistasis.Methods: Simulated data with 2- and 3-loci interactions and tested three different models of epistasis: additive, multiplicative and threshold, were generated using the GAMETES. Penetrance tables were generated using PyTOXO package. For machine learning methods we used multilayer perceptron (MLP), convolutional neural network (CNN) and recurrent neural network (RNN), Lasso regression, random forest and gradient boosting models. Performance of machine learning models were assessed using accuracy, AUC-ROC, AUC-PR, recall, precision, and F1 score.Results: First, we tested ensemble tree methods and deep learning neural networks against LASSO linear regression model on simulated data with different types and strength of epistasis. The results showed that with the increase of strength of epistasis effect, non-linear models significantly outperform linear. Then the higher performance of non-linear models over linear was confirmed on real genetic data for multifactorial phenotypes such as obesity, type 1 diabetes, and psoriasis. From non-linear models, gradient boosting appeared to be the best model in obesity and psoriasis while deep learning methods significantly outperform linear approaches in type 1 diabetes.Conclusion: Overall, our study underscores the efficacy of non-linear models and deep learning approaches in more accurately accounting for the effects of epistasis in simulations with specific configurations and in the context of certain diseases.
- Open Access
- 1 January 2025
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 94 (2) , 38-51
Genetics of lactase deficiency in Russia
Генетика лактазной недостаточности в России
- 1 January 2025
- Published by Geotar-Media Publishing Group in Problems of Nutrition
- Vol. 94 (2) , 38-51
Open AccessGenetics of lactase deficiency in Russia
Генетика лактазной недостаточности в России
- Open Access
- 19 September 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1409714
GWAS and polygenic risk score of severe COVID-19 in Eastern Europe
Background: COVID-19 disease has infected more than 772 million people, leading to 7 million deaths. Although the severe course of COVID-19 can be prevented using appropriate treatments, effective interventions require a thorough research of the genetic factors involved in its pathogenesis.Methods: We conducted a genome-wide association study (GWAS) on 7,124 individuals (comprising 6,400 controls who had mild to moderate COVID-19 and 724 cases with severe COVID-19). The inclusion criteria were acute respiratory distress syndrome (ARDS), acute respiratory failure (ARF) requiring respiratory support, or CT scans indicative of severe COVID-19 infection without any competing diseases. We also developed a polygenic risk score (PRS) model to identify individuals at high risk.Results: We identified two genome-wide significant loci (P-value −8) and one locus with approximately genome-wide significance (P-value = 5.92 × 10−8-6.15 × 10−8). The most genome-wide significant variants were located in the leucine zipper transcription factor like 1 (LZTFL1) gene, which has been highlighted in several previous GWAS studies. Our PRS model results indicated that individuals in the top 10% group of the PRS had twice the risk of severe course of the disease compared to those at median risk [odds ratio = 2.18 (1.66, 2.86), P-value = 8.9 × 10−9].Conclusion: We conducted one of the largest studies to date on the genetics of severe COVID-19 in an Eastern European cohort. Our results are consistent with previous research and will guide further epidemiologic studies on host genetics, as well as for the development of targeted treatments.
- 19 September 2024
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 11, 1409714
Open AccessGWAS and polygenic risk score of severe COVID-19 in Eastern Europe
Background: COVID-19 disease has infected more than 772 million people, leading to 7 million deaths. Although the severe course of COVID-19 can be prevented using appropriate treatments, effective interventions require a thorough research of the genetic factors involved in its pathogenesis.Methods: We conducted a genome-wide association study (GWAS) on 7,124 individuals (comprising 6,400 controls who had mild to moderate COVID-19 and 724 cases with severe COVID-19). The inclusion criteria were acute respiratory distress syndrome (ARDS), acute respiratory failure (ARF) requiring respiratory support, or CT scans indicative of severe COVID-19 infection without any competing diseases. We also developed a polygenic risk score (PRS) model to identify individuals at high risk.Results: We identified two genome-wide significant loci (P-value −8) and one locus with approximately genome-wide significance (P-value = 5.92 × 10−8-6.15 × 10−8). The most genome-wide significant variants were located in the leucine zipper transcription factor like 1 (LZTFL1) gene, which has been highlighted in several previous GWAS studies. Our PRS model results indicated that individuals in the top 10% group of the PRS had twice the risk of severe course of the disease compared to those at median risk [odds ratio = 2.18 (1.66, 2.86), P-value = 8.9 × 10−9].Conclusion: We conducted one of the largest studies to date on the genetics of severe COVID-19 in an Eastern European cohort. Our results are consistent with previous research and will guide further epidemiologic studies on host genetics, as well as for the development of targeted treatments.
- Open Access
- 6 July 2024
- Published by ECO-Vector LLC in Consortium Psychiatricum
- Vol. 5 (2) , 5-15
Genetic Associations of Anhedonia: Insights into Overlap of Mental and Somatic Disorders
BACKGROUND: Anhedonia is characterized by a reduced ability to anticipate, experience, and/or learn about pleasure. This phenomenon has a transdiagnostic nature and is one of the key symptoms of mood disorders, schizophrenia, addictions, and somatic conditions. AIM: To evaluate the genetic architecture of anhedonia and its overlap with other mental disorders and somatic conditions. METHODS: We performed a genome-wide association study of anhedonia on a sample of 4,520 individuals from a Russian non-clinical population. Using the available summary statistics, we calculated polygenic risk scores (PRS) to investigate the genetic relationship between anhedonia and other psychiatric or somatic phenotypes. RESULTS: No variants with a genome-wide significant association were identified. PRS for major depression, bipolar disorder, and schizophrenia were significantly associated with anhedonia. Conversely, no significant associations were found between PRS for anxiety and anhedonia, which aligns well with existing clinical evidence. None of the PRS for somatic phenotypes attained a significance level after correction for multiple comparisons. A nominal significance for the anhedonia association was determined for omega-3 fatty acids, type 2 diabetes mellitus, and Crohn’s disease. CONCLUSION: Anhedonia has a complex polygenic architecture, and its presence in somatic diseases or normal conditions may be due to a genetic predisposition to mood disorders or schizophrenia.
- 6 July 2024
- Published by ECO-Vector LLC in Consortium Psychiatricum
- Vol. 5 (2) , 5-15
Open AccessGenetic Associations of Anhedonia: Insights into Overlap of Mental and Somatic Disorders
BACKGROUND: Anhedonia is characterized by a reduced ability to anticipate, experience, and/or learn about pleasure. This phenomenon has a transdiagnostic nature and is one of the key symptoms of mood disorders, schizophrenia, addictions, and somatic conditions. AIM: To evaluate the genetic architecture of anhedonia and its overlap with other mental disorders and somatic conditions. METHODS: We performed a genome-wide association study of anhedonia on a sample of 4,520 individuals from a Russian non-clinical population. Using the available summary statistics, we calculated polygenic risk scores (PRS) to investigate the genetic relationship between anhedonia and other psychiatric or somatic phenotypes. RESULTS: No variants with a genome-wide significant association were identified. PRS for major depression, bipolar disorder, and schizophrenia were significantly associated with anhedonia. Conversely, no significant associations were found between PRS for anxiety and anhedonia, which aligns well with existing clinical evidence. None of the PRS for somatic phenotypes attained a significance level after correction for multiple comparisons. A nominal significance for the anhedonia association was determined for omega-3 fatty acids, type 2 diabetes mellitus, and Crohn’s disease. CONCLUSION: Anhedonia has a complex polygenic architecture, and its presence in somatic diseases or normal conditions may be due to a genetic predisposition to mood disorders or schizophrenia.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (11) , 122-131
Online phenotypes of depression symptoms are associated with polygenic risk scores of somatic diseases in a population-based cohort
Objective. To test an associations of online phenotypes of depressive symptoms with polygenic risk scores (PRS) for selected somatic diseases in a population-based cohort. Material and methods. Participants in a Russian population-based cohort (n=4520) underwent online phenotyping based on the originally developed questionnaire using DSM-5 criteria (DSM phenotypes) and the Hospital Anxiety and Depression Scale (HADS) questionnaire (HADS phenotypes). After DNA genotyping with microarrays, PRS were calculated using summary statistics from large-scale GWASs (mostly from UK Biobank) for irritable bowel syndrome (IBS), coronary heart disease (narrow and broad phenotypes) (CHD), ischemic stroke (IS),diabetes mellitus type 2 (DT2) and migraine (MG). Then we assessed associations of PRS for somatic diseases with online phenotypes of depressive symptoms in a population-based cohort. Results. Highly specific associations of PRS for somatic diseases with online phenotypes of depressive symptoms in a population cohort were identified: positive associations of PRS IBS with «DSM depression» (p=0.0035) and PRS CHD (narrow phenotype) with «DSM bipolar disorder» (p=0.0207), as well as a negative association of PRS IS with the symptomatic DSM phenotype «Hyperphagia» (p=0.0262). All the HADS phenotypes (clinical depression, subclinical depression, and HADS-D total score) showed a positive association with PRS for IBS and DT2, and at the same time were negatively associated with PRS IS. The DSM phenotype «Hypersomnia and hyperphagia» was positively associated with PRS for DT2 and IS, and negatively associated with PRS CHD (narrow phenotype). The DSM phenotypes «Subclinical Depression», «Hypersomnia», and «Anhedonia» showed exclusively negative associations with PRSs for DT2, IS, and IBS. Three maximum informative PRS by explained variance (PRS.R2) were found for the single DSM phenotype «Hypersomnia and hyperphagia»: PRS for IS and DT2 are positively associated and increase the risk of this phenotype, and PRS CHD (narrow phenotype) has a negative association and reduces the risk of this phenotype. Conclusion. Our study confirmed the presence of possible genetic comorbidity of depression and chronic somatic diseases and showed different effectiveness of online phenotyping of depressive symptoms as markers of genetic risk of somatic diseases in the population cohort. Further research is needed to construct various versions of online phenotyping test systems for population-based screening of cohorts at high genetic risk for genetically comorbid diseases.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (11) , 122-131
Online phenotypes of depression symptoms are associated with polygenic risk scores of somatic diseases in a population-based cohort
Objective. To test an associations of online phenotypes of depressive symptoms with polygenic risk scores (PRS) for selected somatic diseases in a population-based cohort. Material and methods. Participants in a Russian population-based cohort (n=4520) underwent online phenotyping based on the originally developed questionnaire using DSM-5 criteria (DSM phenotypes) and the Hospital Anxiety and Depression Scale (HADS) questionnaire (HADS phenotypes). After DNA genotyping with microarrays, PRS were calculated using summary statistics from large-scale GWASs (mostly from UK Biobank) for irritable bowel syndrome (IBS), coronary heart disease (narrow and broad phenotypes) (CHD), ischemic stroke (IS),diabetes mellitus type 2 (DT2) and migraine (MG). Then we assessed associations of PRS for somatic diseases with online phenotypes of depressive symptoms in a population-based cohort. Results. Highly specific associations of PRS for somatic diseases with online phenotypes of depressive symptoms in a population cohort were identified: positive associations of PRS IBS with «DSM depression» (p=0.0035) and PRS CHD (narrow phenotype) with «DSM bipolar disorder» (p=0.0207), as well as a negative association of PRS IS with the symptomatic DSM phenotype «Hyperphagia» (p=0.0262). All the HADS phenotypes (clinical depression, subclinical depression, and HADS-D total score) showed a positive association with PRS for IBS and DT2, and at the same time were negatively associated with PRS IS. The DSM phenotype «Hypersomnia and hyperphagia» was positively associated with PRS for DT2 and IS, and negatively associated with PRS CHD (narrow phenotype). The DSM phenotypes «Subclinical Depression», «Hypersomnia», and «Anhedonia» showed exclusively negative associations with PRSs for DT2, IS, and IBS. Three maximum informative PRS by explained variance (PRS.R2) were found for the single DSM phenotype «Hypersomnia and hyperphagia»: PRS for IS and DT2 are positively associated and increase the risk of this phenotype, and PRS CHD (narrow phenotype) has a negative association and reduces the risk of this phenotype. Conclusion. Our study confirmed the presence of possible genetic comorbidity of depression and chronic somatic diseases and showed different effectiveness of online phenotyping of depressive symptoms as markers of genetic risk of somatic diseases in the population cohort. Further research is needed to construct various versions of online phenotyping test systems for population-based screening of cohorts at high genetic risk for genetically comorbid diseases.
- Open Access
Genome-wide Association Study of Long COVID
Summary: Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections 1, 2 . Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms of fatigue and pulmonary and cognitive dysfunction 3–5 . The biological mechanisms that contribute to the development of Long COVID remain to be clarified. We leveraged the COVID-19 Host Genetics Initiative 6, 7 to perform a genome-wide association study for Long COVID including up to 6,450 Long COVID cases and 1,093,995 population controls from 24 studies across 16 countries. We identified the first genome-wide significant association for Long COVID at the FOXP4 locus. FOXP4 has been previously associated with COVID-19 severity 6 , lung function 8 , and cancers 9 , suggesting a broader role for lung function in the pathophysiology of Long COVID. While we identify COVID-19 severity as a causal risk factor for Long COVID, the impact of the genetic risk factor located in the FOXP4 locus could not be solely explained by its association to severe COVID-19. Our findings further support the role of pulmonary dysfunction and COVID-19 severity in the development of Long COVID.
Open AccessGenome-wide Association Study of Long COVID
Summary: Infections can lead to persistent or long-term symptoms and diseases such as shingles after varicella zoster, cancers after human papillomavirus, or rheumatic fever after streptococcal infections 1, 2 . Similarly, infection by SARS-CoV-2 can result in Long COVID, a condition characterized by symptoms of fatigue and pulmonary and cognitive dysfunction 3–5 . The biological mechanisms that contribute to the development of Long COVID remain to be clarified. We leveraged the COVID-19 Host Genetics Initiative 6, 7 to perform a genome-wide association study for Long COVID including up to 6,450 Long COVID cases and 1,093,995 population controls from 24 studies across 16 countries. We identified the first genome-wide significant association for Long COVID at the FOXP4 locus. FOXP4 has been previously associated with COVID-19 severity 6 , lung function 8 , and cancers 9 , suggesting a broader role for lung function in the pathophysiology of Long COVID. While we identify COVID-19 severity as a causal risk factor for Long COVID, the impact of the genetic risk factor located in the FOXP4 locus could not be solely explained by its association to severe COVID-19. Our findings further support the role of pulmonary dysfunction and COVID-19 severity in the development of Long COVID.
- 13 June 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (8) , 803-810
Lactase deficiency in Russia: multiethnic genetic study
Background Lactase persistence—the ability to digest lactose through adulthood—is closely related to evolutionary adaptations and has affected many populations since the beginning of cattle breeding. Nevertheless, the contrast initial phenotype, lactase non-persistence or adult lactase deficiency, is still observed in large numbers of people worldwide. Methods We performed a multiethnic genetic study of lactase deficiency on 24,439 people, the largest in Russia to date. The percent of each population group was estimated according to the local ancestry inference results. Additionally, we calculated frequencies of rs4988235 GG genotype in Russian regions using the information of current location and birthplace data from the client’s questionnaire. Results The attained results show that among all studied population groups, the frequency of GG genotype in rs4988235 is higher than the average in the European populations. In particular, the prevalence of lactase deficiency genotype in the East Slavs group was 42.8% (95% CI: 42.1–43.4%). We also investigated the regional prevalence of lactase deficiency based on the current place of residence. Conclusions Our study emphasizes the significance of genetic testing for diagnostics, i.e., specifically for lactose intolerance parameter, as well as the scale of the problem of lactase deficiency in Russia which needs to be addressed by the healthcare and food sectors.
- 13 June 2023
- Published by Springer Nature in European Journal of Clinical Nutrition
- Vol. 77 (8) , 803-810
Lactase deficiency in Russia: multiethnic genetic study
Background Lactase persistence—the ability to digest lactose through adulthood—is closely related to evolutionary adaptations and has affected many populations since the beginning of cattle breeding. Nevertheless, the contrast initial phenotype, lactase non-persistence or adult lactase deficiency, is still observed in large numbers of people worldwide. Methods We performed a multiethnic genetic study of lactase deficiency on 24,439 people, the largest in Russia to date. The percent of each population group was estimated according to the local ancestry inference results. Additionally, we calculated frequencies of rs4988235 GG genotype in Russian regions using the information of current location and birthplace data from the client’s questionnaire. Results The attained results show that among all studied population groups, the frequency of GG genotype in rs4988235 is higher than the average in the European populations. In particular, the prevalence of lactase deficiency genotype in the East Slavs group was 42.8% (95% CI: 42.1–43.4%). We also investigated the regional prevalence of lactase deficiency based on the current place of residence. Conclusions Our study emphasizes the significance of genetic testing for diagnostics, i.e., specifically for lactose intolerance parameter, as well as the scale of the problem of lactase deficiency in Russia which needs to be addressed by the healthcare and food sectors.